Top compounds associated with response to NT5C


Feature Type Standardized
Nominal ANOVA
mRNA BRD-K80183349 CTRPv2 pan-cancer AAC -0.063 0.05
mRNA doxorubicin:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.063 0.05
mRNA GSK690693 GDSC1000 pan-cancer AAC -0.061 0.05
mRNA GDC-0879 CTRPv2 pan-cancer AAC 0.068 0.05
mRNA selumetinib:PLX-4032 (8:1 mol/mol) CTRPv2 pan-cancer AAC 0.068 0.05
mRNA lovastatin CTRPv2 pan-cancer AAC 0.071 0.06
mRNA GW843682X GDSC1000 pan-cancer AAC -0.096 0.06
mRNA 16-beta-bromoandrosterone CTRPv2 pan-cancer AAC -0.071 0.06
mRNA CEP-701 GDSC1000 pan-cancer AAC 0.062 0.06
mRNA Bortezomib GDSC1000 pan-cancer AAC -0.093 0.06
Download CSV